Person with autoimmune Type 1 diabetes (T1D) for 46 years, age 52, blog on topic of diabetes and life with chronic disease. Tweet on same + social justice.
Sep 28, 2022 • 11 tweets • 5 min read
Did you know that each of the "Big 3" Insulin makers sell unbranded versions of their bestselling insulins?
Lilly was the first to introduce Lilly Insulin Lispro back in 2019.
Sep 22, 2022 • 9 tweets • 4 min read
@NovoNordiskLive It would be nice if Novo Nordisk's unbranded insulin strategy in the U.S. wasn't so half-hearted. Why is only a single product in the U.S. unbranded? What's behind that?
@NovoNordiskLive We know according to Novo Nordisk's 2021 annual report that >1 million Americans relied on its unbranded insulins, and yet only a single product is unbranded. That seems half-hearted to me!
Feb 25, 2022 • 8 tweets • 2 min read
Now, will they also act to ensure insulin is not marked-up 1200% by the time it gets to the pharmacy checkout counter? Drug wholesalers play a role and were ID’d by USC’s @SchaefferCenter as drug channel entities helping themselves to money they did not earn on insulin.
Fact: USC research found that PBM's were responsible for 53% of insulin price hikes. The remaining 47% was split among drug wholesalers/distributors and pharmacy chains.
Aug 6, 2021 • 12 tweets • 2 min read
Novo Nordisk CEO Lars Fruergaard Jørgensen said the insulin field is "largely characterized as an interchangeable market" right now, adding "Buyers have been substituting fast-acting insulin brands for years".
